CVS Health Corporation (ETR:CVS)
Germany
· Delayed Price · Currency is EUR | Market Cap | 82.53B |
| Revenue (ttm) | 333.84B |
| Net Income (ttm) | 399.73M |
| Shares Out | n/a |
| EPS (ttm) | 0.32 |
| PE Ratio | 206.46 |
| Forward PE | 10.85 |
| Dividend | 2.36 (3.60%) |
| Ex-Dividend Date | Oct 23, 2025 |
| Volume | 457 |
| Average Volume | 251 |
| Open | 66.11 |
| Previous Close | 63.76 |
| Day's Range | 65.28 - 66.11 |
| 52-Week Range | 41.68 - 73.65 |
| Beta | n/a |
| RSI | 41.30 |
| Earnings Date | Feb 4, 2026 |
About CVS Health
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPs and Medicaid health care management services. It serves employer groups, individuals, coll... [Read more]
Financial Performance
In 2024, CVS Health's revenue was $370.66 billion, an increase of 3.93% compared to the previous year's $356.62 billion. Earnings were $4.61 billion, a decrease of -44.70%.
Financial numbers in USD Financial StatementsNews
CVS Accused Of Years Of Faulty Insulin Refills In $37.8 Million Settlement
Federal prosecutors on Tuesday said Jay Clayton , the U.S. attorney for the Southern District of New York, alleged that CVS Health Inc . (NYSE: CVS) engaged in a years-long pattern of improper billin...
CVS Health (CVS) Settles $37.76M Overbilling Allegations
CVS Health (CVS) Settles $37.76M Overbilling Allegations
17 dividend-stock bargains from a value manager with a stellar track record
John Buckingham, editor of the Prudent Speculator, reminds investors to be “willing to stomach volatility.”
CVS Health to pay $37.76M in settlement for insulin pens claims
CVS Health settles $37.76M for overbilling government health programs on insulin pens. Read more here.
CVS Settles Healthcare Fraud Allegations with $37.76M Payment
CVS Settles Healthcare Fraud Allegations with $37.76M Payment
CVS to pay $37.8 million to settle claims over insulin pens
CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients and then sought reimbursement from government healthcare programs, U.S. Attorney Jay Clayton in ...
Cornerstone Community Development, Winterwood, CVS Health, and Community Organizations Announce the Prichard Centennial Residential Reveal and Next-Phase Preview
HUNTINGTON, W.Va. , Dec. 1, 2025 /PRNewswire/ -- Cornerstone Community Development, in cooperation with Winterwood, CVS Health® (NYSE: CVS) and other community organizations, invites the public and me...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Harrow: Vevye Replaces Xiidra On Tier 1 Formulary At CVS
Harrow, Inc. is experiencing explosive growth, driven by its success in branded pharmaceuticals, especially Vevye. Vevye, HROW's flagship dry eye drug, is projected to reach $100M in 2025 and $300M in...
Forget CVS, Buy This Healthcare Stock Instead
This healthcare stock has struggled this year, but things are suddenly looking up.
CVS Health Delivers MBR Improvement: Is More Progress in the Cards?
CVS posts a sharper MBR as PDR impacts ease and government business strengthens while maintaining a cautious full-year outlook.
These outperforming stocks are still cheap heading into 2026
US stocks have been in a sharp uptrend over the past seven months, with the benchmark S&P 500 index currently up more than 35% versus its year-to-date low in April. Still, a handful of outperformers a...
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?
CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.
CVS vs. WMT: Which Retail Pharmacy Powerhouse Looks Stronger Now?
CVS gains momentum with record revenues, stronger guidance and a cheaper valuation, standing out in the retail pharmacy comparison with WMT.
Abortion pill makers brace for restrictions a year after Trump's election
Federal rules on the abortion pill mifepristone remain unchanged a year after President Donald Trump's election, but an FDA safety review has stirred new uncertainty. State enforcement and lawsuits ar...
Curaechoice Selects CVS Caremark at its PBM
All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies Nationwide Starting January 1 All Active Curaechoice Members and their Families Will Have Access to CVS Pharmacies ...
Wall Street Breakfast Podcast: Ubisoft Cracks Next Level With Tencent
Ubisoft Entertainment (OTCPK:UBSFY) surged nearly 9% after Tencent invested €1.16B in its Vantage Studios, boosting transformation and reducing debt. Tencent (OTCPK:TCEHY) now holds a 26.32% economic ...
CVS Health Corporation (CVS) Appoints J. David Joyner as Chair of the Board
CVS Health Corporation (CVS) Appoints J. David Joyner as Chair of the Board
CVS Announces David Joyner as New Board Chair
CVS Announces David Joyner as New Board Chair
CVS Health Names David Joyner Chair of the Board of Directors
WOONSOCKET, R.I. , Nov. 20, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its Board of Directors has elected President and Chief Executive Officer David Joyner as Chair of the Boar...
CVS Pharmacy® introduces Joyward™, a new brand designed to bring the joy of every moment to life
WOONSOCKET, R.I. , Nov. 20, 2025 /PRNewswire/ -- CVS Pharmacy® today announced the launch of Joyward™, a new line of decor, gifts and more to celebrate the joy of every season.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
CVS Health's Aetna Introduces AI-Powered Assistance for Users
CVS Health's Aetna Introduces AI-Powered Assistance for Users